Zydenar to complete its new drug registration

Published: 2005-12-02 07:00:00

Updated: 2005-12-02 07:00:00

The KFDA has approved a new drug purely developed by a Korean pharmaceutical company called Zydena, an impotence drug, which will be the 10th new drug in Korea following "Factive" of LG Life Science. The KFDA announced on Nov. 29 that Zydenar 100mg and 200mg (udenafil).

The company describes Zydenar (Udenafil) as a phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction, blocking...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.